Literature DB >> 1867524

Interleukin-2 induces early multisystem organ edema mediated by neutrophils.

R Welbourn1, G Goldman, L Kobzik, I Paterson, D Shepro, H B Hechtman.   

Abstract

Interleukin-2 (IL-2), an agent known to activate neutrophils (PMN) with thromboxane (Tx)B2 release, produces pulmonary edema within 6 hours of intravenous infusion. This study tests the role of PMN in mediating the edema. Anesthetized rats received 10(6)U recombinant human IL-2 (n = 15) or vehicle (n = 14) as a constant intravenous infusion during a period of 1 hour. At this time there was leukopenia 3.63 +/- 0.43 (x10(3)/mm3) relative to vehicle-infused control rats 6.12 +/- 0.86 and a decline in PMN, 2.19 +/- 0.14 relative to control value of 3.33 +/- 0.05 (both p less than 0.05). After 6 hours edema, as measured by increase in the wet to dry weight (W/d) ratio, was present in the lungs (4.93 +/- 0.20 relative to control 4.06 +/- 0.10), heart (4.09 +/- 0.11 versus 3.76 +/- 0.08), liver (3.50 +/- 0.10 versus 3.18 +/- 0.10), and kidney (4.25 +/- 0.07 versus 4.00 +/- 0.07) (all p less than 0.05). There was increased lung permeability demonstrated by bronchoalveolar lavage fluid protein concentration of 1970 +/- 210 micrograms/mL relative to control 460 +/- 90 micrograms/mL (p less than 0.05). Interleukin-2 resulted in lung PMN sequestration of 53 +/- 7 PMN/10 high-power fields (HPF) relative to 23 +/- 2 PMN/10 HPF in controls (p less than 0.05) and increased plasma TxB2 levels to 1290 +/- 245 pg/mL relative to control 481 +/- 93 pg/mL (p less than 0.05). Pretreatment of other rats (n = 8) with selective anti-rat neutrophil antiserum 18 hours before the experiment led to a peripheral PMN count 10% of baseline and prevented edema in the lungs (W/d ratio 4.20 +/- 0.16) and heart (3.67 +/- 0.07) (both p less than 0.05) but not liver or kidney. Protein in lung lavage was reduced to 760 +/- 220 micrograms/mL (p less than 0.05). The protection afforded by leukopenia was associated with lack of PMN sequestration and prevention of the increase in plasma Tx levels (484 +/- 120 pg/mL, p less than 0.05). These data indicate that the rapid induction of lung and heart edema with a 1-hour infusion of IL-2 in the rat is mediated, in large part, by activated PMNs.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1867524      PMCID: PMC1358518          DOI: 10.1097/00000658-199108000-00013

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  44 in total

1.  Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon.

Authors:  J S Pober; M A Gimbrone; L A Lapierre; D L Mendrick; W Fiers; R Rothlein; T A Springer
Journal:  J Immunol       Date:  1986-09-15       Impact factor: 5.422

2.  Selective lung leukosequestration after complement activation.

Authors:  J M Klausner; L Kobzik; C R Valeri; D Shepro; H B Hechtman
Journal:  J Appl Physiol (1985)       Date:  1988-07

Review 3.  Neutrophil-mediated vascular injury.

Authors:  J M Harlan
Journal:  Acta Med Scand Suppl       Date:  1987

Review 4.  Capillary plugging by granulocytes and the no-reflow phenomenon in the microcirculation.

Authors:  G W Schmid-Schönbein
Journal:  Fed Proc       Date:  1987-05-15

5.  Interleukin-2 initiates metabolic responses associated with critical illness in humans.

Authors:  H R Michie; T J Eberlein; D R Spriggs; K R Manogue; A Cerami; D W Wilmore
Journal:  Ann Surg       Date:  1988-10       Impact factor: 12.969

6.  Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2.

Authors:  M Rosenstein; S E Ettinghausen; S A Rosenberg
Journal:  J Immunol       Date:  1986-09-01       Impact factor: 5.422

7.  Hematologic effects of immunotherapy with lymphokine-activated killer cells and recombinant interleukin-2 in cancer patients.

Authors:  S E Ettinghausen; J G Moore; D E White; L Platanias; N S Young; S A Rosenberg
Journal:  Blood       Date:  1987-06       Impact factor: 22.113

8.  IL-2-activated human killer lymphocytes but not their secreted products mediate increase in albumin flux across cultured endothelial monolayers. Implications for vascular leak syndrome.

Authors:  N K Damle; L V Doyle
Journal:  J Immunol       Date:  1989-04-15       Impact factor: 5.422

9.  Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1.

Authors:  P P Nawroth; I Bank; D Handley; J Cassimeris; L Chess; D Stern
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

10.  Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins.

Authors:  C Nathan; S Srimal; C Farber; E Sanchez; L Kabbash; A Asch; J Gailit; S D Wright
Journal:  J Cell Biol       Date:  1989-09       Impact factor: 10.539

View more
  6 in total

1.  On-chip evaluation of neutrophil activation and neutrophil-endothelial cell interaction during neutrophil chemotaxis.

Authors:  Donghyuk Kim; Christy L Haynes
Journal:  Anal Chem       Date:  2013-10-28       Impact factor: 6.986

2.  Postoperative enteritis caused by methicillin-resistant Staphylococcus aureus.

Authors:  T Kodama; T Santo; T Yokoyama; Y Takesue; E Hiyama; Y Imamura; Y Murakami; H Tsumura; K Shinbara; N Tatsumoto; Y Matsuura
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

3.  Enhanced expression of cytokine-induced neutrophil chemoattractant (CINC) by bronchoalveolar macrophages in cerulein-induced pancreatitis rats.

Authors:  H Sugita; Y Yamaguchi; S Ikei; S Yamada; M Ogawa
Journal:  Dig Dis Sci       Date:  1997-01       Impact factor: 3.199

4.  Platelet activating factor mediates interleukin-2-induced lung injury in the rat.

Authors:  R Rabinovici; M D Sofronski; J F Renz; L M Hillegas; K M Esser; J Vernick; G Feuerstein
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

Review 5.  Clinical toxicity of interleukin-2.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1992 Nov-Dec       Impact factor: 5.606

6.  High-dose interleukin 2 promotes bacterial translocation from the gut.

Authors:  J V Reynolds; P Murchan; N Leonard; D B Gough; P Clarke; F B Keane; W A Tanner
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.